Project Grant R01DE033004

Award Date 9/5/24
Completion Date 6/30/29
Dollars Obligated $385K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Lincoln, NE 68583, USA
Similar Awards
This $222,500 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research at The Children's Hospital of Philadelphia (CHOP) to investigate the pathogenic mechanisms of temporomandibular joint (TMJ) osteophyte formation. The key objectives are to test whether conditional ablation of the gene EXT1, which is involved in heparan sulfate synthesis, causes osteophyte formation...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), part of the Oral Diseases and Disorders Research program (CFDA 93.121), provides $738,929 to The Trustees of Columbia University in the City of New York to develop and validate a patient-specific TMJ-on-a-chip (TMJOC) model. The TMJOC will be used to investigate multi-tissue crosstalk regulating temporomandibular joint (TMJ) disc injury and healing under inflammation and pathophysiological...
The federal Cooperative Agreement award UH3DE032204 was granted by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program. The $1,660,925.63 award supports a project at Thomas Jefferson University's Sidney Kimmel Medical College to utilize single-cell RNA sequencing to identify and classify cell populations and gene expression in temporomandibular joint (TMJ) synovial fluid from healthy and symptomatic TMJ...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) program, will support research on the role of hyaluronan (HA) in temporomandibular joint (TMJ) health and pathology. The $507,006 award, with a project period from August 1, 2025 to July 31, 2027, will be administered by The Children's Hospital of Philadelphia (CHOP). The key objectives of this research project are to investigate the...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), is providing $1,013,625 to the University of Pittsburgh to investigate the use of a porcine small intestine submucosa (SIS) scaffold for temporomandibular joint (TMJ) disc regeneration. The goal is to develop a safe and effective treatment for TMJ disc replacement, addressing the lack of FDA-approved options that leads to joint...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $429,000.00 to the Regents of the University of Michigan to conduct research on the unique characteristics of jawbone biology. The research aims to gain a molecular-level understanding of how osteoblasts in the jawbone respond differently to bone morphogenetic protein (BMP) signaling and mechanical loading...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $168,228 to Rutgers, The State University of New Jersey to conduct a randomized, placebo-controlled clinical trial on the use of a novel temporo-masseteric nerve block (TMNB) injection to reduce post-surgical pain and improve jaw function following impacted wisdom tooth extractions. The study aims to evaluate the...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $299,782 to develop and validate a novel Jaw Metabolic Stressor (JMS) task. The JMS task is designed to evoke targeted levels of jaw pain and fatigue in both chronic temporomandibular disorder (TMD) pain patients and healthy controls, in order to investigate the peripheral and central neural mechanisms...
This federal Cooperative Agreement award, funded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research grant program (CFDA 93.121), aims to conduct multi-omic investigations of temporomandibular joint (TMJ) disorders. The $587,428 award will support a two-phase project at the University of California, Los Angeles (UCLA) to: 1) develop protocols and infrastructure for data management, subject recruitment, and sample collection; and 2)...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $307,000 Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) to the University of Florida to investigate the expression of cellular senescence markers in gingival tissues of individuals with type 2 diabetes and periodontal disease. The project aims to compare senescence markers in healthy and diseased gingival biopsies between individuals with and without type 2 diabetes, and to correlate senescence...

The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $385,161 project grant on Sep 5, 2024 under the Oral Diseases and Disorders Research (CFDA 93.121) program to the Board of Regents of the University of Nebraska's University of Nebraska Medical Center (UNMC) Division. This grant aims to investigate the role of p21 positive senescent cells in obesity, aging, and trauma-induced temporomandibular joint (TMJ) degeneration, a painful and debilitating joint disease affecting over 20 million Americans. The research will use novel genetically-engineered mouse models to examine the effects of p21 high cells on TMJ osteochondral tissue homeostasis, the pathophysiological mechanisms by which p21 high cells contribute to TMJ degeneration, and the potential to alleviate TMJ osteoarthritis or repair damaged cartilage by clearing p21 high cells after traumatic TMJ injury. The findings have the potential to reveal new regulatory pathways controlling TMJ health and develop innovative therapeutic interventions for this unmet clinical challenge.

Generated 8/5/25, 4:31 AM